| Title: | Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts |
| Journal: | American Journal of Human Genetics |
| Published: | 17 Oct 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/36257325/ |
| DOI: | https://doi.org/10.1016/j.ajhg.2022.09.014 |
| URL: | http://www.cell.com/article/S0002929722004475/pdf |
Publication 10582
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
The true prevalence and penetrance of monogenic disease variants are often not known because of clinical-referral ascertainment bias. We comprehensively assess the penetrance and prevalence of pathogenic variants in HNF1A, HNF4A, and GCK that account for >80% of monogenic diabetes. We analyzed clinical and genetic data from 1,742 clinically referred probands, 2,194 family members, clinically unselected individuals from a US health system-based cohort (n = 132,194), and a UK population-based cohort (n = 198,748). We show that one in 1,500 individuals harbor a pathogenic variant in one of these genes. The penetrance of diabetes for HNF1A and HNF4A pathogenic variants was substantially lower in the clinically unselected individuals compared to clinically referred probands and was dependent on the setting (32% in the population, 49% in the health system cohort, 86% in a family member, and 98% in probands for HNF1A). The relative risk of diabetes was similar across the clinically unselected cohorts highlighting the role of environment/other genetic factors. Surprisingly, the penetrance of pathogenic GCK variants was similar across all cohorts (89%-97%). We highlight that pathogenic variants in HNF1A, HNF4A, and GCK are not ultra-rare in the population. For HNF1A and HNF4A, we need to tailor genetic interpretation and counseling based on the setting in which a pathogenic monogenic variant was identified. GCK is an exception with near-complete penetrance in all settings. This along with the clinical implication of diagnosis makes it an excellent candidate for the American College of Medical Genetics secondary gene list.</p>
16 Authors
- Uyenlinh L Mirshahi
- Kevin Colclough
- Caroline F Wright
- Andrew R Wood
- Robin N Beaumont
- Jessica Tyrrell
- Thomas W Laver
- Richard Stahl
- Alicia Golden
- Jessica M Goehringer
- Geisinger-Regeneron DiscovEHR Collaboration
- Timothy F Frayling
- Andrew T Hattersley
- David J Carey
- Michael N Weedon
- Kashyap A Patel
Enabling scientific discoveries that improve human health